Patient Assistance Programs

Patients with chronic retinal diseases like age-related macular degeneration (AMD) often can’t afford the out-of-pocket co-pay costs for the prescription drugs needed for treatment. 

Privately insured patients, including those who purchase insurance through state insurance exchanges, can seek assistance directly from pharmaceutical-sponsored and independent programs.

Availability and eligibility of patient assistance programs (PAPs) can change at any time, so contact program representatives for current information.


Pharmaceutical-sponsored programs

Allergan, Inc.:
Allergan offers patient assistance for dexamethasone (Ozurdex®) for treatment of retinal vein occlusion (RVO), diabetic macular edema and uveitis. (866) 698-7339, option 4

Bausch + Lomb:
Bausch + Lomb offers patients assistance for pegaptanib sodium (Macugen®), verteporfin (Visudyne®) and fluocinolone acetonide intravitreal implant (Retisert®)

  • Call the Focus on Access hotline at (866) 272-8838

Genentech:

Genentech Ophthalmology Access Solutions is a program that helps people who are taking a Genentech medicine including: VABYSMO® (faricimab-svoa), LUCENTIS® (ranibizumab injection), and SUSVIMO (ranibizumab injection). 

Regeneron Pharmaceuticals:


Independent programs

Independent patient assistance programs (PAPs) offer benefits for patients with Medicare, Medicaid, and private insurance: